Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

20011,749 citationsJournal Articlebronze Open Access

Authors

Jieli Chen · Henry Ford Health System

Yi Li · Henry Ford Health System

Lei Wang · Henry Ford Health System

Zhenggang Zhang · Henry Ford Health System

Dunyue Lu · Henry Ford Health System

Mei Lü · Henry Ford Health System

Michael Chopp ·

Abstract

MSCs delivered to ischemic brain tissue through an intravenous route provide therapeutic benefit after stroke. MSCs may provide a powerful autoplastic therapy for stroke.

Topics & Keywords

Mesenchymal stem cell research Neurogenesis and neuroplasticity mechanisms Pluripotent Stem Cells Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Stroke

Volume 32, Issue 4, pp. 1005-1011

DOI: 10.1161/01.str.32.4.1005

Field-Weighted Citation Impact: 24.06